Whether the response of rectal cancer to nCRT is associated with the somatic mutations of KRAS or APC and infiltration of activated CD4+ T cells, NK cells, dendritic cells, or M2 macrophages should be verified in future investigations. This evidence concerns the gene CD4 and rectal cancer.